iiinova — where your digital self keeps evolving

Nicole Siegal

@nicolesiegal.bsky.social

Health Economist | Postdoc at the O’Neill School of Public and Environmental Affairs at Indiana University sites.google.com/view/nicolesiegal

Posts Replies Media

Reposted by Nicole Siegal

NBER @nber.org · 28/08/2026

When fentanyl deaths hit a county, buprenorphine treatment rises 5 to 17 percent within 1–2 quarters, but only where prescribing capacity already exists, from Siegal, Gupta, Aalsma, Crystal, Miles, Samples, Campbell, Simon, and Liccardo Pacula www.nber.org/papers/w35648

011

Nicole Siegal @nicolesiegal.bsky.social · 05/05/2026

So excited to share my new paper in AJHE! States without triplicate prescription laws saw persistently higher Republican vote shares in presidential elections following OxyContin's release. Thank you to all who provided feedback along the way!

010

Nicole Siegal @nicolesiegal.bsky.social · 18/02/2026

New @jamanetworkopen.com: Recent Medicaid expansions showed significant all-payer buprenorphine treatment increases while earlier expansions did not - suggesting current policy environment enhances effectiveness With @drsumedhagupta.bsky.social, Kosali Simon, & team doi.org/10.1001/jama...

jamanetwork.com

Early vs Recent Medicaid Expansion and Buprenorphine Dispensing

This cross-sectional study evaluates the association of Medicaid expansion with buprenorphine treatment rates and tests whether post-2018 expansions differed from earlier ones.

050